Fundz

MyMD Pharmaceuticals secured $7 million in private placement funding led by PharmaCyte Biotech, Inc.

PRIVATEMay 21, 2024

Amount Raised

$7 Million

Round Type

Post-IPO Equity

BaltimoreBiotechnologyTherapeuticsPharmaceuticalBiopharma

Investors

Existing My Md ShareholdersPharma Cyte Biotech

Description

MyMD Pharmaceuticals, Inc. announced that it has secured $7 million in commitments in two private placement funding rounds led by PharmaCyte Biotech, Inc. An additional $7 million was raised from existing MyMD shareholders participating in the offerings.

Quick answer

MyMD Pharmaceuticals raised $7 Million in a Post-IPO Equity round, dated May 21, 2024. Investors: Existing My Md Shareholders and Pharma Cyte Biotech. MyMD Pharmaceuticals is based in Baltimore, Maryland, United States.

How much did MyMD Pharmaceuticals raise?
MyMD Pharmaceuticals raised $7 Million in a Post-IPO Equity round on May 21, 2024.
Who invested in MyMD Pharmaceuticals?
Existing My Md Shareholders and Pharma Cyte Biotech are named as investors in this round.
What does MyMD Pharmaceuticals do?
MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the causes of disease..
Where is MyMD Pharmaceuticals based and how big is it?
MyMD Pharmaceuticals is based in Baltimore, Maryland, United States.
Who are the decision-makers at MyMD Pharmaceuticals?
Fundz holds 1 contact at MyMD Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as MyMD Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • CASI Pharmaceuticals raised $15M (Post-IPO Equity) on June 26, 2024.
  • CASI Pharmaceuticals raised $15M on June 26, 2024.
  • SystImmune raised $7.2M on May 28, 2024.
  • Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.
  • Bio Green Med Solution, Inc. raised $8M on May 2, 2024.
  • Ajax Therapeutics, Inc. raised $95M on April 26, 2024.

Who to call at MyMD Pharmaceuticals, and when

A new round usually means MyMD Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MyMD Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MyMD Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MyMD Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MyMD Pharmaceuticals

Location

Baltimore, Maryland, United States

About

MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-α, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the rapidly growing CBD market, which includes both FDA approved drugs and CBD products not currently regulated as drugs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MyMD Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for MyMD Pharmaceuticals's next move

See what Strategic adds

MyMD Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.